<?xml version="1.0" encoding="UTF-8"?>
<ref id="zoi201035r7">
 <label>7</label>
 <mixed-citation publication-type="journal">
  <person-group>
   <name name-style="western">
    <surname>Wuerstlein</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Harbeck</surname>
    <given-names>N</given-names>
   </name>
  </person-group>
  <article-title>Neoadjuvant therapy for HER2-positive breast cancer</article-title>. 
  <source>Rev Recent Clin Trials</source>. 
  <year>2017</year>;
  <volume>12</volume>(
  <issue>2</issue>):
  <fpage>81</fpage>-
  <lpage>92</lpage>. doi:
  <pub-id pub-id-type="doi">10.2174/1574887112666170202165049</pub-id>
  <?supplied-pmid 28164759?>
  <pub-id pub-id-type="pmid">28164759</pub-id>
 </mixed-citation>
</ref>
